Literature DB >> 2315261

Verapamil-induced inhibition of theophylline elimination in healthy humans.

J E Nielsen-Kudsk1, J S Buhl, A C Johannessen.   

Abstract

The interaction between theophylline and verapamil was investigated in 7 healthy volunteers. Oral administration of verapamil in a dose of 120 mg t.i.d. for 7 days caused a significant inhibition of the elimination of theophylline (5 mg/kg intravenously). Theophylline clearance was reduced from 45.2 to 36.1 ml/hr/kg (20.1%; P less than 0.005). The apparent steady-state volume of distribution of the drug was not influenced. The terminal half-life of theophylline was increased from 6.80 to 8.23 hr (21.0%; P less than 0.001). Increased steady-state plasma theophylline concentrations may thus be expected when verapamil is added to a drug regimen which includes theophylline.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315261     DOI: 10.1111/j.1600-0773.1990.tb00713.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  8 in total

1.  Verapamil and drug metabolism by the cytochrome P450 isoform CYP1A2.

Authors:  U Fuhr; B G Woodcock; M Siewert
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

3.  Induction of cytochrome P450 1A by cow milk-based formula: a comparative study between human milk and formula.

Authors:  Haibo Xu; Ratheishan Rajesan; Patricia Harper; Richard B Kim; Bo Lonnerdal; Mingdong Yang; Satoko Uematsu; Janine Hutson; Jo Watson-MacDonell; Shinya Ito
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 4.  Clinically significant pharmacokinetic interactions between dietary caffeine and medications.

Authors:  J A Carrillo; J Benitez
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

Review 5.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

6.  Identification of P450 enzymes involved in metabolism of verapamil in humans.

Authors:  H K Kroemer; J C Gautier; P Beaune; C Henderson; C R Wolf; M Eichelbaum
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

7.  Volume of Distribution is Unaffected by Metabolic Drug-Drug Interactions.

Authors:  Jasleen K Sodhi; Caroline H Huang; Leslie Z Benet
Journal:  Clin Pharmacokinet       Date:  2021-02       Impact factor: 5.577

Review 8.  [Drug interactions and the anesthesiologist].

Authors:  A S Milde; J Motsch
Journal:  Anaesthesist       Date:  2003-09       Impact factor: 1.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.